The State Institute for Drug Control (SÚKL) assessed the
objections raised by the Health Insurance Association (“the Association”) and
the General Health Insurance Company (VZP) concerning the allegedly
unacceptable budget impact of the evaluated treatment on the public health
insurance system.
The Association’s calculations were based on a comparison of
per-patient treatment costs – CZK...
Are you interested in reading regular commentaries on decisions by Pharmeca a.s.? Feel free to contact us.
At Pharmeca, we help you navigate the complex landscape of pharmaceutical and medical device information. We also offer flexible services that can be tailored to your needs at any time.
Our market position and experience allow us to support you whenever you need expert guidance.
Our knowledge, your opportunity.
